Riva-Quetiapine 100 mg
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety, Contamination
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| Bottle Size: 100 tabs: | A. Riva-Quetiapine 100 mg | - Recalling Firm
- Laboratoire Riva Inc.
- 660 Industrial Blvd.
- Blainville
- J7C 3V4
- Quebec
- CANADA
- Marketing Authorization Holder
- Laboratoire Riva Inc.
- 660 Industrial Blvd.
- Blainville
- J7C 3V4
- Quebec
- CANADA
| Tablet | DIN 02316706 | 100 mg / tablet |
Recalled products
-
Riva-Quetiapine 100 mg
Potential cross-contamination of trace amounts of Clindamycin in Quetiapine Active Pharmaceutical Ingredient during the manufacturing process.
Wholesalers and pharmacies in Quebec, Ontario, and British-Columbia